Login to Your Account



Genome Therapeutics, Genesoft To Merge In $80M All-Stock Deal

By Randall Osborne


Wednesday, November 19, 2003
Genome Therapeutics Inc. and Genesoft Pharmaceuticals Inc. said they have entered a definitive agreement for an all-stock merger that would leave the new entity with one antibiotic preparing to launch and another in Phase III trials. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription